HYAL1 and neoplasm: The role of HYAL1 as a tumor suppressor or oncogene remains unclear [12–18] with reports of both HYAL1 downregulation in human endometrial cancer and lung and kidney carcinomas [12, 13] and upregulation in breast, epithelial ovarian, and bladder tumors [16–18].